HomepageEarnings Events Newsdesk 3 days ago Axon Enterprise, Inc. (AXON) Sec Form 8K Axon Enterprise, Inc. (NASDAQ: AXON) Sec Form 8K AbbVie (ABBV) AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026 » « Bruker Corp (BRKR) Sec Form 8K Newsdesk:
